The 2001 European Commission proposal for the registration, evaluation, and authorization of chemicals (REACH) aims to protect public and environmental health by assessing the toxicity of, and restricting exposure to, potentially toxic chemicals. The requirements for carcinogenicity testing of industrial chemicals, regulated by REACH, are based on a tiered approach according to which, a two-year carcinogenicity assay may be required for certain chemicals marketed at more than 1000 metric tons per year. Additionally, some chemicals that are found to be genotoxic will also require carcinogenicity testing.
Our team and experience
Our team includes both highly qualified senior study directors and technicians with broad expertise in the areas described below.
To conduct carcinogenicity studies requires an in-depth knowledge of the spontaneous frequency of certain pathological changes, as there may be substantial differences between species and strains. Our carcinogenicity group is skilled at performing histopathological assessments in rodent carcinogenicity studies, applying standard diagnostic criteria across the large numbers of tissues examined following RITA (Registry of Industrial Toxicology Animal-data) standards. Special preparations may be included in addition to standard staining methodology to further characterize any observed tissue lesions
Carcinogenicity studies for Chemicals
- Carcinogenicity studies (rats or mice) (OECD 451)
- Combined chronic toxicity/carcinogenicity studies (OECD 453)
You may also be interested in…
Our team of experienced, highly-educated scientists, experts in toxicology, molecular biology, chemistry and immunology, fully understands that the drug development process is distinct for each approach
Inhalation toxicity studies are required to assess the exposure hazards of consumer products or to manufacturing workers
Our in-house team of veterinarians ensures that animal welfare is paramount and is fully committed to the principles of the 3Rs (replacement, reduction, refinement).